Analyst Ratings for Unum
Unum (NYSE:UNM) has observed the following analyst ratings within the last quarter:
What 7 Analyst Ratings Have To Say About Unum
Within the last quarter, Unum (NYSE:UNM) has observed the following analyst ratings:
8 Analysts Have This to Say About Unum
Over the past 3 months, 8 analysts have published their opinion on Unum (NYSE:UNM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
JP Morgan Maintains Neutral on Unum, Raises Price Target to $42
JP Morgan analyst Jimmy Bhullar maintains Unum (NYSE:UNM) with a Neutral and raises the price target from $36 to $42.
Truist Securities Maintains Buy on Unum, Raises Price Target to $48
Truist Securities analyst Mark Hughes maintains Unum (NYSE:UNM) with a Buy and raises the price target from $44 to $48.
10 Financials Stocks Moving In Monday’s Pre-Market Session
Gainers
Silver Crest Acquisition (NASDAQ:SLCR) shares increased by 12.4% to $7.99 during Monday's pre-market session. The company's market cap stands at $344.5 million.
Raymond James Initiates Coverage On Unum with Market Perform Rating
Raymond James analyst Wilma Burdis initiates coverage on Unum (NYSE:UNM) with a Market Perform rating.
9 Analysts Have This to Say About Unum
Over the past 3 months, 9 analysts have published their opinion on Unum (NYSE:UNM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
HCA Healthcare To Surge About 20%, Plus This Analyst Increases PT On Netflix
Raymond James raised the price target for HCA Healthcare, Inc. (NYSE: HCA) from $230 to $250. HCA Healthcare shares rose 0.4% to close at $208.97 on Thursday.